体外診断用医薬品（IVD）品質管理の世界市場レポート 2025年

体外診断用医薬品（IVD）品質管理の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.7％で20億9,000万米ドルに成長します。予測期間の成長は、個別化医療の進展、ポイントオブケア検査の拡大、デジタルヘルスの統合、次世代シーケンシング（NGS）の採用、世界の健康セキュリティへの懸念、電子カルテ（EHR）との統合などに起因します。予測期間における主な動向としては、多項目品質管理材料、AIおよび機械学習用途、オンデマンド品質管理ソリューション、継続的モニタリングとリアルタイムフィードバック、ポータブルで使いやすい品質管理機器などが挙げられます。

HIVやがんなどの感染症の増加は、体外診断用医薬品品質管理市場の成長の重要な原動力です。これらの感染症は、ウイルス、細菌、真菌、寄生虫などの様々な病原体によって引き起こされるため、効果的な治療のためには高度な診断検査製品やサービスが必要となります。HIVやがんを含む感染症の急増は、検査機器や検査結果の正確性、性能、品質を保証する体外診断用医薬品品質管理に対する需要の高まりを裏付けています。国家統計局の報告によると、2022年12月9日週末の時点で、イングランドで35歳から69歳の個人と学校に通う12歳から24歳の人々の感染率が増加したとのことです。したがって、HIVやがんなどの感染症の増加が、体外診断用医薬品品質管理市場の成長を促進すると予想されます。

慢性疾患の増加は、体外診断用医薬品（IVD）品質管理市場の需要を牽引すると予測されます。慢性疾患は進行が遅く、長期間持続することが特徴であるため、正確で信頼性の高い診断検査を保証する体外診断用医薬品品質管理の役割は極めて重要です。このことがひいては正確で信頼できる臨床結果を促進します。2023年1月に国立医学図書館が発表した報告書によると、米国では50歳以上で少なくとも1つの慢性疾患を持つ人の数は、2050年までに1億4,200万人に達すると予測されています。2050年には1億4,266万人に達すると予測されています。したがって、慢性疾患の急増は体外診断用医薬品（IVD）品質管理市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の体外診断用医薬品（IVD）品質管理市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の体外診断用医薬品（IVD）品質管理市場の成長率分析
• 世界の体外診断用医薬品（IVD）品質管理市場の実績：規模と成長、2019～2024年
• 世界の体外診断用医薬品（IVD）品質管理市場の予測：規模と成長、2024～2029年、2034年
• 世界の体外診断用医薬品（IVD）品質管理総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の体外診断用医薬品（IVD）品質管理市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 品質管理製品
• データ管理ソリューション
• 品質保証サービス
• 世界の体外診断用医薬品（IVD）品質管理市場：メーカータイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• IVD機器メーカー
• サードパーティの品質管理メーカー
• 世界の体外診断用医薬品（IVD）品質管理市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 臨床化学
• 血液学
• 免疫測定
• 分子診断
• 微生物学
• 凝固または止血
• その他の用途
• 世界の体外診断用医薬品（IVD）品質管理市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 臨床検査室
• 研究学術機関
• その他のエンドユーザー
• 世界の体外診断用医薬品（IVD）品質管理市場：品質管理製品のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• コントロール材料
• 品質管理キット
• 能力テストサンプル
• 世界の体外診断用医薬品（IVD）品質管理市場：データ管理ソリューションのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 品質管理ソフトウェア
• データ分析ツール
• クラウドベースソリューション
• 世界の体外診断用医薬品（IVD）品質管理市場：品質保証サービスのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• コンサルティングサービス
• トレーニングおよび教育サービス
• 監査およびコンプライアンスサービス

第7章 地域別・国別分析

• 世界の体外診断用医薬品（IVD）品質管理市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の体外診断用医薬品（IVD）品質管理市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 体外診断用医薬品（IVD）品質管理市場：競合情勢
• 体外診断用医薬品（IVD）品質管理市場：企業プロファイル
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • LGC Limited. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Roche Diagnostics AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Siemens AG
• Ortho Clinical Diagnostics Inc.
• Helena Laboratories Corporation
• Quidel Corporation
• Microbiologics Inc.
• Sun Diagnostics LLC
• Fortress Diagnostics Ltd.
• Seegene Inc.
• Bio-Techne Corp.
• Randox Laboratories
• Danaher Corporation
• Sysmex Corporation
• Beckman Coulter Inc.
• Grifols India Healthcare Private Limited.
• Hologic Inc.

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 体外診断用医薬品（IVD）品質管理市場2029年-最も新しい機会を提供する国
• 体外診断用医薬品（IVD）品質管理市場2029年-最も新しい機会を提供するセグメント
• 体外診断用医薬品（IVD）品質管理市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

In-vitro diagnostics (IVD) quality control encompasses a set of processes designed to ensure the accuracy, performance, and environmental conditions impacting in vitro diagnostic tests, including in vitro nucleic acid testing processes for pathogen detection and healthcare-associated infections (HAIs) like pneumonia and urinary tract infections.

The primary products in in-vitro diagnostics quality control include quality control products, data management solutions, and quality assurance services. Quality control products comprise serum/plasma-based control products, whole blood-based control products, urine-based control products, and other control products manufactured by IVD instrument manufacturers. These products aim to cure, mitigate, or treat conditions through in-vitro diagnostics quality control. Manufacturers can be categorized as IVD instrument manufacturers and third-party quality control manufacturers. These products find applications in various diagnostic areas, such as clinical chemistry, hematology, immunoassay, molecular diagnostics, microbiology, coagulation, or hemostasis, among others. The implementation of in-vitro diagnostics quality control occurs in various settings, including hospitals, clinical laboratories, research and academic institutes, and other healthcare facilities.

The in-vitro diagnostics (IVD) quality control market research report is one of a series of new reports from The Business Research Company that provides in-vitro diagnostics (IVD) quality control market statistics, including in-vitro diagnostics (IVD) quality control industry global market size, in-vitro diagnostics (IVD) quality control market regional shares, competitors with an in-vitro diagnostics (IVD) quality control market share, detailed in-vitro diagnostics (IVD) quality control market segments, in-vitro diagnostics (IVD) quality control market trends and opportunities, and any further data you may need to thrive in the in-vitro diagnostics (IVD) quality control industry. This in-vitro diagnostics (IVD) quality control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vitro diagnostics (IVD) quality control market size has grown strongly in recent years. It will grow from $1.4 billion in 2024 to $1.49 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to regulatory compliance, increasing prevalence of diseases, growing aging population, expansion of diagnostic laboratories, increased awareness and demand for precision medicine.

The in vitro diagnostics (IVD) quality control market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to personalized medicine advancements, point-of-care testing expansion, digital health integration, adoption of next-generation sequencing (NGS), global health security concerns, integration with electronic health records (EHR). Major trends in the forecast period include multi-analyte quality control materials, ai and machine learning applications, on-demand quality control solutions, continuous monitoring and real-time feedback, portable and easy-to-use quality control devices.

The increase in the prevalence of infectious diseases, such as HIV and cancer, is a significant driver of the growth observed in the in vitro diagnostics quality control market. These infectious diseases, caused by various pathogens like viruses, bacteria, fungi, or parasites, necessitate advanced diagnostic testing products and services for effective treatment. This surge in infectious diseases, including HIV and cancer cases, underscores the growing demand for in vitro diagnostics quality control, ensuring the accuracy, performance, and quality of test equipment and results. As reported by the Office for National Statistics, the infection rate in England increased for individuals aged 35 to 69 years and those in school years 12 to 24 years by the end of the week ending December 9, 2022. Hence, the expected rise in infectious diseases, such as HIV and cancer, is poised to propel the growth of the in vitro diagnostics quality control market in the forecast years.

The increasing prevalence of chronic diseases is anticipated to drive the demand for the in-vitro diagnostics (IVD) quality control market in the foreseeable future. Chronic diseases, characterized by slow progression and long-term persistence, underscore the crucial role of in vitro diagnostics quality control in ensuring accurate and reliable diagnostic tests. This, in turn, facilitates precise and trustworthy clinical results. A report from the National Library of Medicine in January 2023 indicates that the number of people in the US aged 50 and older with at least one chronic condition is projected to reach 142. 66 million by 2050. Therefore, the surge in chronic diseases is a key factor propelling the growth of the in-vitro diagnostics (IVD) quality control market.

Increasing research and development is influencing the in vitro diagnostics quality control market. Major companies in the in vitro diagnostics (IVD) quality control sector are creating innovative products to gain a competitive edge. For example, in November 2023, Newland EMEA, a Netherlands-based digital technology company, unveiled a new line of in vitro diagnostics (IVD) products at the MEDICA trade fair. This lineup includes five advanced barcode scanners designed specifically for the healthcare sector, such as the high-speed FM510 and FM530, along with the versatile FM550 and the intelligent FM600 camera. These scanners aim to enhance automation in IVD processes, leading to improvements in diagnostic speed and accuracy. This launch highlights Newland EMEA's dedication to advancing technology in automatic identification and data collection, ultimately focusing on enhancing patient care through more efficient healthcare solutions.

In May 2024, Bruker, a US-based analytical instrumentation company, acquired ELITechGroup for €870 ($948) million. This acquisition aims to strengthen Bruker's position in the molecular diagnostics market by integrating ELITech's innovative sample-to-answer platforms along with its diverse portfolio of assays for infectious diseases. ELITech, also a US-based in-vitro diagnostics company, develops, manufactures, and markets a wide range of advanced diagnostic products and solutions, which include instruments, reagents, and software.

Major companies operating in the in vitro diagnostics (IVD) quality control market include Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., LGC Limited., Abbott Laboratories, Roche Diagnostics AG, Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc., Qiagen NV, Becton Dickinson and Company, Luminex Corporation, BioMerieux SA, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ZeptoMetrix Corporation, Maine Molecular Quality Controls Inc.

North America was the largest region in the in vitro diagnostics (IVD) quality control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics (ivd) quality control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the in vitro diagnostics (ivd) quality control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The in-vitro diagnostics (IVD) quality control market consists of revenues earned by entities that evaluate and validate the reliability of in-vitro diagnostics testing systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics (IVD) Quality Control Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostics (ivd) quality control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics (ivd) quality control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro diagnostics (ivd) quality control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product type: Quality Control Products; Data Management Solutions; Quality Assurance Services
• 2) By Manufacturer Type: IVD Instrument Manufacturers; Third Party Quality Control Manufacturers
• 3) By Application: Clinical Chemistry; Hematology; Immunoassay; Molecular Diagnostics; Microbiology; Coagulation Or Hemostasis; Other Applications
• 4) By End-Users: Hospitals; Clinical Laboratories; Research And Academic Institutes; Other End Users
• Subsegments:
• 1) By Quality Control Products: Control Materials; Quality Control Kits; Proficiency Testing Samples
• 2) By Data Management Solutions: Software For Quality Control Management; Data Analysis Tools; Cloud-Based Solutions
• 3) By Quality Assurance Services: Consulting Services; Training And Education Services; Audit And Compliance Services
• Companies Mentioned: Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; LGC Limited.; Abbott Laboratories; Roche Diagnostics AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostics (IVD) Quality Control Market Characteristics

3. In Vitro Diagnostics (IVD) Quality Control Market Trends And Strategies

4. In Vitro Diagnostics (IVD) Quality Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global In Vitro Diagnostics (IVD) Quality Control Growth Analysis And Strategic Analysis Framework

• 5.1. Global In Vitro Diagnostics (IVD) Quality Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global In Vitro Diagnostics (IVD) Quality Control Market Growth Rate Analysis
• 5.4. Global In Vitro Diagnostics (IVD) Quality Control Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global In Vitro Diagnostics (IVD) Quality Control Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global In Vitro Diagnostics (IVD) Quality Control Total Addressable Market (TAM)

6. In Vitro Diagnostics (IVD) Quality Control Market Segmentation

• 6.1. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Quality Control Products
• Data Management Solutions
• Quality Assurance Services
• 6.2. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• IVD Instrument Manufacturers
• Third Party Quality Control Manufacturers
• 6.3. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Chemistry
• Hematology
• Immunoassay
• Molecular Diagnostics
• Microbiology
• Coagulation Or Hemostasis
• Other Applications
• 6.4. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinical Laboratories
• Research And Academic Institutes
• Other End Users
• 6.5. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Quality Control Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Control Materials
• Quality Control Kits
• Proficiency Testing Samples
• 6.6. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Data Management Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software For Quality Control Management
• Data Analysis Tools
• Cloud-Based Solutions
• 6.7. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Quality Assurance Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Training And Education Services
• Audit And Compliance Services

7. In Vitro Diagnostics (IVD) Quality Control Market Regional And Country Analysis

• 7.1. Global In Vitro Diagnostics (IVD) Quality Control Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global In Vitro Diagnostics (IVD) Quality Control Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market

• 8.1. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Vitro Diagnostics (IVD) Quality Control Market

• 9.1. China In Vitro Diagnostics (IVD) Quality Control Market Overview
• 9.2. China In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Vitro Diagnostics (IVD) Quality Control Market

• 10.1. India In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Vitro Diagnostics (IVD) Quality Control Market

• 11.1. Japan In Vitro Diagnostics (IVD) Quality Control Market Overview
• 11.2. Japan In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Vitro Diagnostics (IVD) Quality Control Market

• 12.1. Australia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Vitro Diagnostics (IVD) Quality Control Market

• 13.1. Indonesia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Vitro Diagnostics (IVD) Quality Control Market

• 14.1. South Korea In Vitro Diagnostics (IVD) Quality Control Market Overview
• 14.2. South Korea In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In Vitro Diagnostics (IVD) Quality Control Market

• 15.1. Western Europe In Vitro Diagnostics (IVD) Quality Control Market Overview
• 15.2. Western Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In Vitro Diagnostics (IVD) Quality Control Market

• 16.1. UK In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In Vitro Diagnostics (IVD) Quality Control Market

• 17.1. Germany In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In Vitro Diagnostics (IVD) Quality Control Market

• 18.1. France In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In Vitro Diagnostics (IVD) Quality Control Market

• 19.1. Italy In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In Vitro Diagnostics (IVD) Quality Control Market

• 20.1. Spain In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market

• 21.1. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market Overview
• 21.2. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In Vitro Diagnostics (IVD) Quality Control Market

• 22.1. Russia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In Vitro Diagnostics (IVD) Quality Control Market

• 23.1. North America In Vitro Diagnostics (IVD) Quality Control Market Overview
• 23.2. North America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In Vitro Diagnostics (IVD) Quality Control Market

• 24.1. USA In Vitro Diagnostics (IVD) Quality Control Market Overview
• 24.2. USA In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In Vitro Diagnostics (IVD) Quality Control Market

• 25.1. Canada In Vitro Diagnostics (IVD) Quality Control Market Overview
• 25.2. Canada In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In Vitro Diagnostics (IVD) Quality Control Market

• 26.1. South America In Vitro Diagnostics (IVD) Quality Control Market Overview
• 26.2. South America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In Vitro Diagnostics (IVD) Quality Control Market

• 27.1. Brazil In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In Vitro Diagnostics (IVD) Quality Control Market

• 28.1. Middle East In Vitro Diagnostics (IVD) Quality Control Market Overview
• 28.2. Middle East In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In Vitro Diagnostics (IVD) Quality Control Market

• 29.1. Africa In Vitro Diagnostics (IVD) Quality Control Market Overview
• 29.2. Africa In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In Vitro Diagnostics (IVD) Quality Control Market Competitive Landscape And Company Profiles

• 30.1. In Vitro Diagnostics (IVD) Quality Control Market Competitive Landscape
• 30.2. In Vitro Diagnostics (IVD) Quality Control Market Company Profiles
  • 30.2.1. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. LGC Limited. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Roche Diagnostics AG Overview, Products and Services, Strategy and Financial Analysis

31. In Vitro Diagnostics (IVD) Quality Control Market Other Major And Innovative Companies

• 31.1. Siemens AG
• 31.2. Ortho Clinical Diagnostics Inc.
• 31.3. Helena Laboratories Corporation
• 31.4. Quidel Corporation
• 31.5. Microbiologics Inc.
• 31.6. Sun Diagnostics LLC
• 31.7. Fortress Diagnostics Ltd.
• 31.8. Seegene Inc.
• 31.9. Bio-Techne Corp.
• 31.10. Randox Laboratories
• 31.11. Danaher Corporation
• 31.12. Sysmex Corporation
• 31.13. Beckman Coulter Inc.
• 31.14. Grifols India Healthcare Private Limited.
• 31.15. Hologic Inc.

32. Global In Vitro Diagnostics (IVD) Quality Control Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Vitro Diagnostics (IVD) Quality Control Market

34. Recent Developments In The In Vitro Diagnostics (IVD) Quality Control Market

35. In Vitro Diagnostics (IVD) Quality Control Market High Potential Countries, Segments and Strategies

• 35.1 In Vitro Diagnostics (IVD) Quality Control Market In 2029 - Countries Offering Most New Opportunities
• 35.2 In Vitro Diagnostics (IVD) Quality Control Market In 2029 - Segments Offering Most New Opportunities
• 35.3 In Vitro Diagnostics (IVD) Quality Control Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer